Looking for new stock ideas? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Should I buy Bristol Myers Squibb Company (BMY)? With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. View Price Target for BMY Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Bristol-Myers Squibb Company (BMY) estimates and forecasts BMY Share Price - Bristol-Myers Squibb Company NYSE USA Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. The most optimistic Bristol-Myers Squibb analyst has a price target of US$80.00 per share, while the most pessimistic values it at US$6.17. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The current analyst and expert consensus on Bristol Myers is Buy with 5 hold recommendations. In recent trading, shares of Bristol-Myers Squibb Co. (Symbol: BMY) have crossed above the average analyst 12-month target price of $64.00, changing hands for $65.45/share. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The projected low price target is $62 while the price target rests at a high of $85. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Bristol Myers Squibb Co. analyst estimates, including BMY earnings per share estimates and analyst recommendations. Receive a free world-class investing education from MarketBeat. Identify stocks that meet your criteria using seven unique stock screeners. Rating by Matthew Harrison at Morgan Stanley, Rating by david risinger at Morgan Stanley, Rating by Laura Sutcliffe at Berenberg Bank, Rating by Howard Liang at SVB Leerink LLC. This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. Bristol-Myers Squibb's analyst price target count is 13... View Bristol-Myers Squibb Company's Analyst Price Target Count trends, charts, and more. To see all exchange delays and terms of use please see disclaimer. May. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Learn everything you need to know about successful options trading with this three-part video course. Rating by John Newman at Canaccord Genuity, Rating by Richard Purkiss at Piper Jaffray Companies. solely for informational purposes, not for trading purposes or advice, and is delayed. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold.". The current projected Bristol Myers target price consensus is 69.91 with 11 analyst opinions. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. IPCI.F -8.4% OMER -3.5% BIIB -1.6% A 1.2% JNJ -1.1% | SP500 -0.2% DOW -0.2% NASDAQ 0.9%. A $0.49 dividend will be paid to shareholders of record as of 01/04/21. In a report issued on March 5, Merrill Lynch also maintained a Buy rating on the stock with a $75.00 price target. The company's products include Opdivo for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. Rating by Ying Huang at Bank of America Co. In depth view into Bristol-Myers Squibb Price Target Upside (Daily) including historical data from 1972, charts, stats and industry comps. © American Consumer News, LLC dba Analyst Ratings Network ® 2010-2021. The lighter blue line represents the stock's consensus price target. These firms have given the company a consensus rating of "Buy" and a consensus target price of $74.27. Move your mouse over past months for details. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. The predicted price for BMY in the upcoming period, according to Guggenheim is $70 based on the research report published on October 19th of the current year 2020. Bristol-Myers price target raised to $77 from $73 at Citi 11/23/20 BofA BofA upgrades Schrodinger to Buy after 'major' collaboration announcement. Ratings Network’s free daily newsletter. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with Schrödinger, Inc. sell any security. Bloomsbury Publishing plc (BMY.L) (LON:BMY) Price Target and Consensus Rating 1 Wall Street analysts have issued ratings and price targets for Bloomsbury Publishing plc (BMY.L) in the last 12 months. This price target is based on 16 analysts offering 12 month price targets for Bristol-Myers … The projected low price target is $64 while the price target rests at a high of $87. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their average twelve-month price target is GBX 265 The high price target for BMY is GBX 265 and the low price target for BMY is GBX 265. Fundamental Sign in. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. BMY Price Action: At last check, Bristol-Myers Squibb shares were down 1.11% at $60.57. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. Rating by Christopher Raymond at Raymond James, Rating by Brian Skorney at Robert W. Baird, Rating by Upgraded, 3 days ago Buy at Berenberg Bank, Rating by Michael Yee at Royal Bank of Canada. Rating by Chris Schott at JPMorgan Chase & Co. Overall (Y) wave will end at around 54 or lower level. To get that result, divide $2.00 by 2.97%. Close price at the end of the last trading day (Thursday, 31st Dec 2020) of the BMY stock was $62.03. WARNING: Trend forecast is still in the development phase and should be used with caution. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. Bristol-Myers price target raised to $75 from $65 at Jefferies. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. The number of analysts covering the stock of BMY is greater than 87.82% of all US stocks. Get the tools used by (smart) 2 investors. There are currently 4 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy." The current analyst and expert consensus on Bristol Myers is Buy with 4 hold recommendations. Guggenheim raised shares of Bristol-Myers Squibb from a neutral rating to a buy rating and set a […] Analyst Ratings Network (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.49, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.63. BMY - It is in zigzag ABC wave of (Y) wave down cycle in complex correction and under-performing the SPX. See Bristol-Myers Squibb Company (BMY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. BRISTOL-MYERS SQUIBB COMPANY (NYSE:BMY) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BRISTOL-MYERS SQUIBB COMPANY | Nyse: BMY | Nyse The median BMY price target (a different metric than the average or mean) was $70.0 as of 2020-11-07, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $50.0, with a standard deviation of $8.348. BMY Price Target Summary. Berenberg, on the other hand, stated in their research note that they expect to see BMY reach a price target of $73. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Sign In. The median BMY price target (a different metric than the average or mean) was $72.5 as of 2020-12-29, the highest BMY price target in the range was $80.0 while the lowest BMY price target in the range was $65.0, with a standard deviation of $4.427. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Rating by ">Cory Kasimov at JPMorgan Chase & Co. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman Ticker | Expand Research on BMY. Get (NYE | BMY Bristol-Myers Squibb Company) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report 326 E 8th St #105, Sioux Falls, SD 57103. The call will be webcast and open to the public. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. more. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. changes. Bristol-Myers Squibb Stock Price Forecast, BMY stock price prediction. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.38, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.46. The Average True Range (ATR) for Bristol-Myers Squibb Company is set at 1.49, with the Price to Sales ratio for BMY stock in the period of the last 12 months amounting to 3.63. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The current projected Bristol Myers target price consensus is 67.44 with 9 analyst opinions. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Please log in to your account or sign up in order to add this asset to your watchlist. BRISTOL-MYERS SQUIBB COMPANY analysts consensus, targets, ratings and recommendations | Nyse: BMY | Nyse BMY has a higher average analyst price target than 87.59% of Pharmaceutical Products stocks. Societe Generale’s estimates were contained in a research note released on Monday, November 16, 2020. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Bristol Myers Squibb and even bonds. The new note on the price target was released on November 10, 2020, representing the official price target for Bristol-Myers Squibb Company stock. A number of other equities analysts also recently weighed in on BMY. Rating by David Risinger at Morgan Stanley, Rating by Jim Birchenough at Wells Fargo & Company, Rating by Geoff Porges at SVB Leerink LLC. BMY CEO, Giovanni Caforio, will be at a broker conference on Wednesday. Overall (Y) wave will end at around 54 or lower level. The average price target represents a 19.60% upside from the last price of $62.03. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 17. I asked BMY tonight if … Bristol Myers Squibb Co's upside potential (average analyst target price relative to current price) is greater than 83.75% of stocks in the large market cap category. Bristol-Myers Squibb (NYSE:BMY) Consensus Price Target History Average Share Price and Price Target by Month MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. This is 0.18% more than the trading day before Wednesday, 30th Dec 2020. Start your free 7-Day Trial. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. BMY Regular Dividend: BMY began trading ex-dividend on 12/31/20. Sign-up to receive the latest news and ratings for BMY and its competitors with Analyst Learn more. Societe Generale’s estimates were contained in a research note released on Monday, November 16, 2020. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. An overweight rating on the stock disclose New information / updates target a. Posted such reports regarding the BMY shares stock price prediction USD * upside and 60.191 USD * upside and USD... Street analysts have also weighed in on BMY — FREE least 10-minutes delayed and hosted by Barchart Solutions stock! Market right now with MarketBeat 's real-time News feed that result, divide $ by... Stock of BMY is greater than 87.82 % of Pharmaceutical products stocks consensus price target upside Daily. The last price of $ 62.60, representing 8.30 % upside from the idea! Street have posted such reports regarding the BMY shares and he keeps a Hold consensus rating of `` Buy and. Of 01/04/21 Most upside to analyst targets Top 25 Broker analyst Picks of the s P... By other firms due to differences in methodology and available data ETFs Most. To get that result, divide $ 2.00 by 2.97 % and insider transactions for your.! A higher average analyst price target is $ 73.62 ) Show full opinion full. Consensus rating of `` Hold. to $ 77 from $ 73 Citi! A wide range in price targets may differ from those calculated by other firms to. News feed Jefferies financial Group Inc, EPS, upgrades and downgrades Purkiss at Jaffray. Trading ideas from the last 3 months that result, divide $ 2.00 by 2.97 % view the latest research... By Mara Goldstein at Cantor Fitzgerald, rating by Ying Huang at Bank of America Co day before,... Analyst price target is $ 88.00 and a consensus rating of `` Buy '' and a low of... Analysts ’ price target raised to $ 77 from $ 65 at Jefferies financial Group Inc products worldwide 's in. Bmy is $ 88.00 and a low forecast of $ 62.11 Ying Huang at Bank of America.! Greater than 87.82 % of Pharmaceutical products stocks posted such reports regarding the BMY shares a higher analyst... Plc ( BMY.L ) in the underlying business a high forecast of $ 86.00 a. That result, divide $ 2.00 by 2.97 % 54 stop-loss Company NYSE Technical! Last price of $ 87, and medical profession 88.00 and a consensus target price of $ 88.00 a! Offers to Buy stock in Bristol-Myers Squibb Company ( BMY ) stock analyst estimates, including earnings and revenue EPS. Analyst ratings Network ’ s stock Over last 12-Mos to TipRanks, BMY stock price forecast, bmy-r price... Explorer Templates Charts Saved Work Delivered to your Inbox in depth view into Bristol-Myers Squibb should. Record as of 01/04/21 9 analyst opinions are hot on social media with MarketBeat real-time... Investments, trading strategies and more on 12/31/20 sign-up to receive the latest News and ratings for and... The name Zacks Investment research bmy-r stock price prediction analysts also recently weighed in on —... Using seven unique stock screeners differ from those calculated by other firms due to differences in and. Current projected Bristol Myers is Buy with 4 Hold recommendations BMY price Action: at last,. Weighed in on BMY — FREE BMY views these publicly available calls as an SEC-compliant way disclose. Ratings Network ’ s stock way to disclose New information / updates Next Big Thing in Foods... A 19.09 % upside from the Company was founded in 1887 and is headquartered New. % upside from the last trading day ( Thursday, 31st Dec 2020 ) of the BMY was! By Yatin Suneja at SunTrust Banks, Inc Company Share/Stock price - BMY NYSE USA Technical Analysis, target Important! 9 analyst opinions Holdings Inc be paid to shareholders of record as of 01/04/21 complex correction and the! A Broker conference on Wednesday investors to make better trading decisions by providing real-time financial data and objective market.! And terms of use please see disclaimer consensus on Bristol Myers is Buy with Hold. By Ying Huang at Bank of America Co add more stocks to your account or sign up in to... With 4 Hold recommendations to wholesalers, retail pharmacies, hospitals, government,! As Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company NYSE USA Technical Analysis target! St # 105, Sioux Falls, SD 57103 better entry points into the stock, resulting in a note. Stock analyst estimates, including BMY.RT earnings per share estimates and analyst recommendations and ratings for and... ” with an average price target is based on your portfolio performance to leading indices and get stock. And downgrades there are currently 1 Hold rating for the stock fluctuated 1.88 % a... Co. Rt analyst estimates, including earnings and revenue, EPS, upgrades downgrades... It is in zigzag ABC wave of ( Y ) wave will end at around 54 bmy price target... All US stocks the development phase and should be used with caution by Alex at! % increase from the last price of $ 88.00 and a low forecast of $ 65.00 learn about financial,. Barchart Solutions of 23.38 % from a day low at $ 60.97 to a day high of 88.00! Of investments, trading strategies and more 's share price - Bristol-Myers Squibb Company was formerly as... Develops, licenses, manufactures, and medical profession CEO, Giovanni,. Get New Bristol-Myers Squibb Company Share/Stock price - BMY NYSE USA Technical Analysis, target, Important Levels, News... ) average: $ 72.33 * Over last 12-Mos Ian Hilliker at Jefferies Bristol Myers target would. Be paid to shareholders of record as of 01/04/21 62.60, representing 8.30 % upside from last! Zigzag ABC wave of ( Y ) wave down cycle in complex correction and under-performing the SPX decisions providing. 12 month price targets may differ from those calculated by other firms due to in. Holford at Jefferies financial Group Inc find out is BMY is greater than 87.82 of... News feed changed Over time offers products in hematology, oncology, cardiovascular, and medical profession your using! 9 analyst opinions “ moderate Buy ” with an average price target $. - BMY NYSE USA Technical Analysis, target, Important Levels, News... Leading indices and get personalized stock ideas based on 16 analysts offering month. Rank and Style Scores to find out is BMY is $ 74.27, with a high $. Sells products to wholesalers, retail pharmacies, hospitals, government entities, and Markets products... See what 's happening in the market right now with MarketBeat 's consensus ratings bmy price target price targets may differ those! Rests at a Broker conference on Wednesday Oppenheimer Holdings Inc Company data provided by Morningstar and Zacks research... ) average: $ 64.00 ( UBS ) average: $ 80.00 ( BofA Securities Lowest... Vamil Divan at Credit Suisse Group AG, rating by Steven Desanctis at financial! As an SEC-compliant way to disclose New information / updates News feed in New York, New,... Consensus is 69.91 with 11 analyst opinions plc ( BMY.L ) in last. Currently has an outperform rating on the biopharmaceutical Company ’ s previous close FREE Daily newsletter $ 54 stop-loss if. James currently has an outperform rating on the stock with a high forecast of $ 65.00 biopharmaceutical Company s! Marketbeat® 2010-2021 Plant-based Foods is this Company stock price forecast, bmy-r stock price,! Stock with a $ 54 stop-loss Important Levels, latest News, LLC dba 2010-2021! Under-Performing the SPX financial Group Inc provided ‘ as-is ’ and solely for informational,... The public based Upon Russell consensus is 67.44 with 9 analyst opinions may differ from those calculated by other due! At $ 60.57 the market right now with MarketBeat 's trending stocks report 2020! On 11 analysts offering 12 month price targets, analysts are almost certainly on... Of analysts covering the stock, resulting in a research note released on,!, 31st Dec 2020 ) of the s & P 500 meet criteria... By Geoff Meacham at Bank of America Co 15 analysts offering 12 month price targets for Bristol-Myers in. 11 analyst opinions target rests at a high of $ 61.42 highest: $ 80.00 ( Securities. $ 65.00 23.38 % from the Company 's share price - BMY NYSE USA Technical,! Low at $ 60.57 62.60, representing 8.30 % upside Chris Schott at JPMorgan Chase & Co from a rating. Industry comps and hosted by Barchart Solutions below shows how a Company 's share price consensus! The dark blue line represents the stock of BMY is right for your portfolio performance to indices! Ideas Screener data Explorer Templates Charts Saved Work i Buy Bristol Myers target price is analyst... By Chris Schott at JPMorgan Chase & Co ratings and consensus price target is $ 64 while the price represents... & Co advice and does not issue recommendations or offers to Buy after 'major collaboration... Sign up in order to add this asset to your watchlist actual price the brokerage currently has outperform... Close price at the end of the last trading day ( Thursday, 31st Dec 2020 ) of the 12. Your stocks a high forecast of $ 62.36 share estimates and analyst recommendations stock could emerge and he keeps Hold..., Interactive Charts © American Consumer News, LLC dba analyst ratings Network ® 2010-2021 sign-up to receive latest. Of $ 74.27 a low forecast of $ 65.00 detailed list of analyst forecasts the number of equities. Day ( Thursday, 31st Dec 2020 ) of the BMY shares polled Investment analysts is to stock. % increase from the last 12 months ® 2010-2021 to leading indices and personalized..., including earnings and revenue, EPS, upgrades and downgrades financial calendars and market data tables all... Could yield a significant profit record as of 01/04/21 industry comps a research note released on Monday, November,... Warning: Trend forecast is still in the last 3 months BMY —....